Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Current Deferred Revenue (2024 - 2025)

Rallybio (RLYB) has disclosed Current Deferred Revenue for 2 consecutive years, with $212000.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 75.0% to $212000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $212000.0 through Dec 2025, down 75.0% year-over-year, with the annual reading at $212000.0 for FY2025, 75.0% down from the prior year.
  • Current Deferred Revenue hit $212000.0 in Q4 2025 for Rallybio, down from $424000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.2 million in Q2 2024 to a low of $212000.0 in Q4 2025.